Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-01 · accession 0001104659-26-009764 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | RYTM | Garfield Alastair | CSO | M - OptEx | — | +6,663 | 9,789 | +213% | — |
| D | 2026-02-03 | 2026-02-01 | RYTM | Garfield Alastair | CSO | F - Tax | $108.99 | -2,026 | 7,763 | -21% | -$220.8K |
| D | 2026-02-03 | 2026-02-01 | RYTM | Garfield Alastair | CSO | M - OptEx | $0.00 | -6,663 | 20.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-01 | M | A | 6,663 | — | 9,789 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Common | Common Stock | 2026-02-01 | F | D | 2,026 | $108.99 | 7,763 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-02-01 | M | D | 6,663 | $0.00 | 19,987 | D | — · — to — | 6,663 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest as to 25% of the total shares on each of February 1, 2026, February 1, 2027, February 1, 2028 and February 1, 2029. The restricted stock units have no expiration date. |